192 related articles for article (PubMed ID: 11850791)
1. Clinical utility of telomerase in cancer.
Hiyama E; Hiyama K
Oncogene; 2002 Jan; 21(4):643-9. PubMed ID: 11850791
[TBL] [Abstract][Full Text] [Related]
2. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
3. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
[TBL] [Abstract][Full Text] [Related]
4. Telomerase: its clinical relevance in the diagnosis of bladder cancer.
Müller M
Oncogene; 2002 Jan; 21(4):650-5. PubMed ID: 11850792
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
7. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
10. [Telomerase].
Tsuji N; Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():137-41. PubMed ID: 12652801
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of telomerase reverse transcriptase (TERT) protein in benign and malignant tumor cells of the breast.
Ikeda S; Shibata T; Funakoshi N
Rinsho Byori; 2005 Jun; 53(6):487-93. PubMed ID: 16026073
[TBL] [Abstract][Full Text] [Related]
13. [Telomerase activity of common malignant tumors].
Liu X; Zou Y; Guo C
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):25-7. PubMed ID: 11783063
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
Crocitto LE; Korns D; Kretzner L; Shevchuk T; Blair SL; Wilson TG; Ramin SA; Kawachi MH; Smith SS
Urology; 2004 Oct; 64(4):821-5. PubMed ID: 15491741
[TBL] [Abstract][Full Text] [Related]
15. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
17. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase expression in oral carcinogenesis--a preliminary report.
Kumar SK; Zain RB; Ismail SM; Cheong SC
J Exp Clin Cancer Res; 2005 Dec; 24(4):639-46. PubMed ID: 16471328
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]